Professor, Medicine, Stony Brook University SOM
Infectious Disease
Dr. Roy T. Steigbigel, MD
|
|
Give Review
Dr. Roy T. Steigbigel is an expert in the field of Infectious Disease. He attended University of Rochester School of Medicine and Dentistry. He received 1 awards: "Whos Who in Medicine and Healthcare". Steigbigel is a published doctor and has 90 publications published. The lastest was: 'Albumin synthesis and bone collagen formation in human immunodeficiency virus-positive subjects: differential effects of growth hormone administration.' Doctor Roy T. Steigbigel, MD is registered with Medicare.
Publications
- Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.
- A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection.
- Nef inhibits glucose uptake in adipocytes and contributes to insulin resistance in human immunodeficiency virus type I infection.
- Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1...
- Images in clinical medicine. Nodular Clostridium difficile colitis.
- Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone: a pilot study.
- Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.
- Interleukin 2 and HIV RNA Levels.
- Osteopenia in patients with HIV infection is not associated with elevated sTNFR2 levels.
- Evaluation of cellular immune responses in subjects chronically infected with HIV type 1.
- Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza.
- Antigen burden is major determinant of human immunodeficiency virus-specific CD8+ T cell maturation state: potential implications for therapeutic immunization.
- A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral ...
- Severe malnutrition in a young man with AIDS.
- Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system.
- Changes in parietal cell structure and function in HIV disease.
- Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trial...
- A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages.
- Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodes.
- A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group.
- Rochalimaea's role in cat scratch disease and bacillary angiomatosis.
- A comparison of the Coulter STKS, Coulter S+IV, and manual analysis of white blood cell differential counts in a human immunodeficiency virus-infected population.
- In situ detection of PCR-amplified HIV-1 nucleic acids in lymph nodes and peripheral blood in patients with asymptomatic HIV-1 infection and advanced-stage AIDS.
- Detection of human immunodeficiency virus (HIV) by colorimetric assay for reverse transcriptase activity on magnetic beads.
- Chemiluminescent enzyme-linked immunoassay for reverse transcriptase, illustrated by detection of HIV reverse transcriptase.
- Colorimetric reverse transcriptase assay for HIV-1.
- Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue.
- Poly A-linked colorimetric microtiter plate assay for HIV reverse transcriptase.
- Method of reliable determination of minimal lethal antibiotic concentrations.
- Mechanism of lethal effect of human serum upon Leishmania donovani.
- Phagocytosis and killing of the protozoan Leishmania donovani by human polymorphonuclear leukocytes.
- Well-tolerated bacteremia of five years' duration.
- Transfusion malaria: treatment with exchange transfusion after delayed diagnosis.
- Effects of erythromycin in combination with penicillin, ampicillin, or gentamicin on the growth of Listeria monocytogenes.
- Candida parapsilosis infection of a total hip-joint replacement: successful reimplantation after treatment with amphotericin B and 5-fluorocytosine. A case report.
- An atypical subcutaneous infection associated with acquired immune deficiency syndrome.
- Staphylococcal beta-lactamase and efficacy of beta-lactam antibiotics: in vitro and in vivo evaluation.
- Pre-Kaposi's sarcoma.
- Elevated adenosine cyclic 3'',5''-monophosphate levels in human macrophages following their interaction with Salmonella typhimurium.
- Clostridium perfringens wound infection associated with elastic bandages.
- Mitogen responses and interferon production after exposure of human macrophages to infectious and inactivated influenza viruses.
- Letter: Cephaloridine.
- A case of phaeohyphomycosis caused by a new species of Phialophora.
- Pneumocystis carinii pneumonia presenting as localized nodular densities.
- The nitroblue tetrazolium reduction test versus conventional hematology in the diagnosis of bacterial infection.
- Acute myeloproliferative disorder following long-term chlorambucil therapy.
- Phagocytic and bacterial properties of normal human monocytes.
- A solid-phase enzyme immunoassay (Gonozyme) test for direct detection of Neisseria gonorrhoeae antigen in urogenital specimens from patients at a sexually transmitted ...
- Interaction of human eosinophils with Leishmania donovani.
- Candida pericarditis and tamponade in a patient with systemic lupus erythematosus.
- Recurrent toxic shock syndrome in a man: possible role of IgA deficiency.
- Role of the Vi antigen of Salmonella typhi in resistance to host defense in vitro.
- Normal T cell subsets in homosexual men living in a community without endemic AIDS.
- Varicella zoster virus transverse myelitis without cutaneous rash.
- Factors determining pulmonary deposition of aerosolized pentamidine in patients with human immunodeficiency virus infection.
- Determination of salivary anticandidal activities in healthy adults and patients with AIDS: a pilot study.
- Pilot study comparing the salivary cationic protein concentrations in healthy adults and AIDS patients: correlation with antifungal activity.
- Antibiotic combinations in the treatment of experimental Staphylococcus aureus infection.
- Clinical and laboratory studies into the pathogenesis of malacoplakia.
- Polymorphonuclear leukocyte, monocyte, and macrophage bactericidal function in patients with Hodgkin''s disease.
- Infective endocarditis and access site infections in patients on hemodialysis.
- Hereditary deficiency of the fifth component of complement in man. II. Biological properties of C5-deficient human serum.
- Effect of in vitro virus infection on response of human monocytes and lymphocytes to mitogen stimulation.
- Hyperthermia and human leukocyte functions: effects on response of lymphocytes to mitogen and antigen and bactericidal capacity of monocytes and neutrophils.
- Renal hematuria associated with adenovirus 7a infection.
- Complement, serum bactericidal activity, and disseminated gram-negative infection.
- Granulocyte bactericidal capacity and chemotaxis as affected by continuous-flow centrifugation and filtration leukapheresis, steroid administration, and storage.
- Acidosis of synovial fluid correlates with synovial fluid leukocytosis.
- Albumin synthesis and bone collagen formation in human immunodeficiency virus-positive subjects: differential effects of growth hormone administration.
- Immunization against Lyme disease--an important first step.
- Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical...
- Anti-F(ab')2 antibody in HIV type 1 infection: relationship to hypergammaglobulinemia and to antibody specific to the V3 loop region of glycoprotein 120.
- Responsiveness of muscle protein synthesis to growth hormone administration in HIV-infected individuals declines with severity of disease.
- Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor.
- In situ detection of PCR-amplified HIV-1 and EBV nucleic acids in hyperplastic lymph nodes and in AIDS-related lymphoma.
- Impairment of phagosome-lysosome fusion in HIV-1-infected macrophages.
- Analysis of fatal pulmonary hantaviral infection in New York by reverse transcriptase in situ polymerase chain reaction.
- Eosinophilia in patients infected with human immunodeficiency virus.
- Predictors of HIV-specific lymphocyte proliferative immune responses induced by therapeutic vaccination.
- Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy.
- Insulin-like growth factor system in patients with HIV infection: effect of exogenous growth hormone administration.
- Targeting pandemic influenza: a primer on influenza antivirals and drug resistance.
- Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection.
- Combined tipranavir and enfuvirtide use associated with higher plasma tipranavir concentrations but not with increased hepatotoxicity: sub-analysis from RESIST.
- Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 re...
- Treatment of HIV infection with raltegravir.
- Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.
- Raltegravir with optimized background therapy for resistant HIV-1 infection.
- Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection.
Schools
University Of Rochester School Of Medicine and Dentistry
Strong Memorial Hospital
Stanford University Hospital
Stanford Palo Alto Med Rsch
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Capital District Physician's Health Plan (CDPHP) HMO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Emblem Health
- GHI PPO
- Health Insurance Plan of Greater New York (HIP) PPO
- Empire Blue Cross Blue Shield HMO
- Prism Blue Priority EPO
- Fidelis Care HMO
- HealthFirst
- Choice Care PPO
- Locals (any local)
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Neighborhood Health Plan
- Freedom Plan
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Awards
- Whos Who in Medicine and Healthcare
Education
-
Stanford University -
University of Rochester -
University of Rochester School of Medicine and Dentistry
Hospital
-
Stony Brook University Medical Center
Drug Facts
| NPI NUMBER | 1609891134 | |
| NPPES Provider LastName | STEIGBIGEL | |
| NPPES Provider FirstName | ROY | |
| NPPES Provider ZIPCode | 11733 | |
| NPPES Provider State | NY | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 31.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609891134 |
| Last Name Of The Provider | STEIGBIGEL |
| First Name Of The Provider | ROY |
| View All |
Similar Doctors
|
|
Dr. Susan V. Donelan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Galinkin, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Khalid M. Ahmad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William H. Greene, MD |
|
|
Dr. Roderick A. Go, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rekha Sivadas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nardeen Mickail, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan A. Krohn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jack Fuhrer, MD
This Doctor is OpenDoctor Recommended.
|